The Current Ratio as of September 2024 (TTM) for Surgalign Holdings, Inc. (SRGA) is 2.67

According to Surgalign Holdings, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 2.67. This represents a change of 11.32% compared to the average of 2.40 of the last 4 quarters.

Surgalign Holdings, Inc. (SRGA) Historical Current Ratio (quarterly & annually)

How has SRGA Current Ratio performed in the past?

The mean historical Current Ratio of Surgalign Holdings, Inc. over the last ten years is 2.72. The current 2.67 Current Ratio has changed 9.72% with respect to the historical average. Over the past ten years (40 quarters), SRGA's Current Ratio was at its highest in in the June 2013 quarter at 4.66. The Current Ratio was at its lowest in in the June 2020 quarter at 0.64.

Surgalign Holdings, Inc. (SRGA) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Surgalign Holdings, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Surgalign Holdings, Inc. (SRGA) Average Current Ratio

How has SRGA Current Ratio performed in the past?

The current Current Ratio of Surgalign Holdings, Inc. (SRGA) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Surgalign Holdings, Inc. (SRGA) Current Ratio vs. Peers

How is SRGA’s Current Ratio compared to its peers?

Surgalign Holdings, Inc.’s Current Ratio is greater than NuVasive, Inc. (1.25), less than Paragon 28, Inc. (3.57), greater than Orthofix Medical Inc. (2.48), less than SI-BONE, Inc. (9.17), greater than Avanos Medical, Inc. (2.28), greater than Aziyo Biologics, Inc. (0.87), less than Establishment Labs Holdings Inc. (4.44), less than CVRx, Inc. (10.08), less than AxoGen, Inc. (3.51), less than Talis Biomedical Corporation (7.76), less than Heart Test Laboratories, Inc. (4.20), less than Tivic Health Systems, Inc. (7.89), less than Bone Biologics Corporation (11.22), greater than Bioventus Inc. (1.33), less than Surmodics, Inc. (3.98), less than Biomerica, Inc. (3.51), less than Movano Inc. (5.76), greater than Ainos, Inc. (1.48), greater than INVO Bioscience, Inc. (0.30), less than Hyperfine, Inc. (8.08), less than Inogen, Inc. (2.70), greater than Accelerate Diagnostics, Inc. (1.28), less than Apyx Medical Corporation (5.33),

Build a custom stock screener for Surgalign Holdings, Inc. (SRGA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Surgalign Holdings, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Surgalign Holdings, Inc. (SRGA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Surgalign Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.